期刊文献+

阿尔茨海默病免疫治疗的困境与希望

原文传递
导出
摘要 阿尔茨海默病(AD)是一种常见的神经系统退行性疾病,是最常见的痴呆类型。目前,全球AD患者约有3560万,随着人口的老龄化,AD患者还将不断增加,但现时尚无有效的防治方法。自1984年发现β-
作者 王延江
出处 《人民军医》 2011年第S1期69-71,共3页 People's Military Surgeon
  • 相关文献

参考文献10

  • 1Vellas B,Coley N,Andrieu S.Disease modifying trials in Alzheimer’’sdisease:Perspectives for the future. Journal of Alzheimer s Disease . 2008
  • 2Schor NF.What the halted phaseⅢgamma-secretase inhibitor trialmay (or may not)be telling us. Annals of Neurology . 2011
  • 3Hyman BT.Amyloid-dependent and amyloid-independent stages ofAlzheimer disease. Archives of Neurology . 2011
  • 4Wang YJ,Zhou HD,Zhou XF.Modified immunotherapies againstAlzheimer’’s disease:Toward safer and effective amyloid-beta clearance. Journal of Alzheimer s Disease . 2010
  • 5Schenk D,Barbour R,Dunn W,et al.Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature . 1999
  • 6Wang YJ,Zhou HD,Zhou XF.Clearance of amyloid-beta in Alzhei-mer’s disease:progress,problems and perspectives. Drug Discov To-day . 2006
  • 7Holmes C,Boche D,Wilkinson D,et al.Long-term effects of Abeta42immunisation in Alzheimer‘s disease:follow-up of a randomised,placebo-controlled phase I trial. The Lancet . 2008
  • 8ZS Khachaturian.Revised criteria for diagnosis of Alzheimer’s disease: National Institute on Aging-Alzheimer’s Association diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement . 2011
  • 9Petrushina I,Ghochikyan A,Mktrichyan Met al.Alzheimer’’sdisease peptide vaccine reduces insoluble but not soluble/olimericAβspecies in Amyloid precursor protein transgenic mice. TheJournal of Neuroscience . 2007
  • 10S Salloway,R Sperling,S Gilman,NC Fox,K Blennow,M Raskind,M Sabbagh,LS Honig,R Doody,CH Dyck,R Mulnard,J Barakos,KM Gregg,E Liu,I Lieberburg,D Schenk,R Black,M Grundman.A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology . 2009

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部